Alpha-1 Antitrypsin (AAT) Enhances Islet Autograft Survival in Patients With Chronic Pancreatitis
Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
Primary objective: To describe and compare the safety and efficacy of treatment with AAT in
chronic pancreatitis patients who undergo total pancreatectomy and islet autotransplantation
(TP-IAT).